{"nctId":"NCT00759525","briefTitle":"The Role of Mineralocorticoid Receptors in Vascular Function","startDateStruct":{"date":"2002-02"},"conditions":["Apparent Mineralocorticoid Excess (AME)"],"count":15,"armGroups":[{"label":"1","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Glycyrrhetic Acid"]},{"label":"2","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Glycyrrhetic Acid","otherNames":["licorice root sweetener"]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Healthy volunteers\n\nExclusion Criteria:\n\n* Blood pressure above 140/90\n* Abnormal physical finding\n* Blood test values for total and LDL cholesterol, CBC, sodium, potassium, creatinine, and glucose laboratories greater 1.5 times normal","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","maximumAge":"85 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Forearm Blood Flow","description":"At the end of each 14-day intervention (Glycyrrhinitic acid or Placebo), vascular endothelial function was assessed by measuring forearm blood flow and comparing to Baseline. The outcome measure depicted below reflects the change in forearm blood flow from Baseline after completing the glycyrrhinitic acid regimen as well as the change in forearm blood flow from Baseline after taking the matching placebo.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.87","spread":"0.26"},{"groupId":"OG001","value":"1.34","spread":"0.20"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":7},"commonTop":[]}}}